When was Endostream founded?

Endostream was founded in 2014.

Where is Endostream located?

Endostream is headquartered in Tel Aviv, Israel.

How many employees does Endostream have?

As of Mar 31, 2026, the latest employee count at Endostream is 20.

Is Endostream a funded company?

Endostream is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Endostream rank among its competitors?

Endostream ranks 6th amongst 37 active competitors, of which 12 are funded. It stands 11th in terms of total funding among its competitors.

Who are the top competitors of Endostream?

Endostream's top competitors include Rapid Medical, Fluid Biomed and Penumbra.

Endostream - 2026 Company Profile, Team, Funding & Competitors

Endostream is an acquired company based in Tel Aviv (Israel), founded in 2014 by Alon May and Danel Mayer. It operates as a [Stealth] Medical device for the treatment of cerebral aneurysms. The company has 37 active competitors, including 12 funded and 14 that have exited. Its top competitors include companies like Rapid Medical, Fluid Biomed and Penumbra.

Company Details

EndoStream is an early stage medical device company focussed on developing a device for the treatment of cerebral aneurysms. Based on its patent-pending technology, it is developing its flagship product. As of December 2016, the company is operating in stealth mode & hasn't disclosed its product details.

Key Metrics

Founded Year

2014

Location

Tel Aviv, Israel

Stage

Acquired

Investors

Peregrine Ventures & 2 more

Ranked

6^th among 37 active competitors

Employee Count

20 as on Mar 31, 2026

Similar Companies

Rapid Medical & 49 more

Exit Details

Acquired by Kaneka (Jan 09, 2025)

View Endostream's full profile

Endostream got acquired by Kaneka on Jan 09, 2025.

Click here to take a look at Endostream's acquisition in detail

Endostream is a funded company. Endostream has 3 institutional investors.

View details of Endostream's funding rounds and investors

The founders of Endostream are Alon May and Danel Mayer.

Here are the details of Endostream's key team members:

Alon May: Co-Founder & COO of Endostream.
Danel Mayer: Co-Founder & CEO of Endostream.

View details of Endostream's Founder profiles and Board Members

Endostream's employee count trend

Endostream has 20 employees as of Mar 26. Here is Endostream's employee count trend over the years:

Uncover Endostream's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Endostream include Rapid Medical, Fluid Biomed and Penumbra. Here is the list of Top 10 competitors of Endostream, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Rapid Medical 2008, Yokneam Illit (Israel), Series D	Developer of neurovascular interventional devices such as distal access & microcatheters	$79M	Agate, CPE & 8 others	61/100
2nd	Fluid Biomed 2012, Calgary (Canada), Series A	Developer of medical device to treat brain aneurysms	$32.5M	Amplitude, Amino Capital & 11 others	61/100
3rd	Penumbra 2004, Alameda (United States), Public	Developer of medical devices for neurovascular and peripheral thrombectomy	$121K	Novo Holdings, The Angels’ Forum & 4 others	58/100
4th	Anaconda Biomed 2015, Barcelona (Spain), Series B	Developer of medical devices for mechanical thromboectomy procedures	$39M	Omega Funds, Ysios Capital & 6 others	54/100
5th	MicroVention 1997, Tustin (United States), Acquired	Catheter-based, minimally invasive neuroendovascular technologies	-	Domain Associates, Lightstone Ventures & 4 others	50/100
6th	Endostream 2014, Tel Aviv (Israel), Acquired	[Stealth] Medical device for the treatment of cerebral aneurysms	-	Peregrine Ventures, Net Capital Ventures & 1 others	36/100
7th	Sequent Medical 2007, Aliso Viejo (United States), Acquired	Catheter-based neurovascular devices	$65.3M	Versant Ventures, Domain Associates & 4 others	45/100
8th	Cerus Endovascular 2011, Oxford (United Kingdom), Acquired	Devices for minimally invasive treatment of Intracranial Aneurysms	$8.21M	Johnston Associates, The North West Fund & 3 others	45/100
9th	Acandis 2006, Pforzheim (Germany), Funding Raised	Developer of products for the treatment of hemorrhagic and ischemic strokes	-	S-Kap & 1 others	44/100
10th	Metactive Medical 2011, Olathe (United States), Series A	Endovascular devices for the treatment of peripheral and neurovascular diseases	$10.2M	NIH, National Heart Lung and Blood Institute ... & 5 others	42/100